Most people take medication expecting it to solve a problem and then quietly become part of their routine. But some treatments can create unexpected challenges when it comes time to stop.
According to NHS guidance, NHS England prescription data and comments from herbal practitioner Simon Mills discussed on The Diary of a CEO podcast, growing attention is being paid to the long-term use of proton pump inhibitors (PPIs), LADbible.
Among them is Omeprazole, one of the most commonly prescribed medications for heartburn and acid reflux in the UK.
Two concerns
Omeprazole works by reducing stomach acid production, helping relieve symptoms linked to reflux, indigestion and heartburn.
Also read: How dark chocolate affects the heart according to cardiologists
While the medication remains an important treatment for many patients, experts say two issues are increasingly being discussed. The first relates to potential health risks associated with prolonged use.
Long-term risks
According to NHS information, extended use has been linked to:
- Increased risk of gut infections
- Higher risk of bone fractures
- Pneumonia
- Low magnesium levels
- Delayed diagnosis of certain stomach cancers
The second concern involves a phenomenon known as rebound acid production. When some people stop taking the medication, their stomach temporarily produces extra acid, causing symptoms to return or become more noticeable.
Seeking medical advice
Because of this rebound effect, stopping Omeprazole can be difficult for some patients.
Also read: How much alcohol is safe? New study provides a clear answer
Health experts recommend speaking with a doctor before making changes to treatment. Depending on individual circumstances, gradual dose reduction may help ease the transition.
Specialists also stress that prescribed medication should never be stopped without professional medical guidance.
Also read: 1.5 million people studied: These beverages may be linked to liver cancer
Also read: That ringing in your ears may be telling you something important
This article is made and published by Mie Hermansen, who may have used AI in the preparation.